Immune Cell Subsets in SLE Patients Treated with Telitacicept
Clinical trial NCT06677801 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06677801
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-11
- Primary completion
- 2026-10-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.